Beta Bionics Insider Trades
NASDAQ: BBNXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 35 · $4.10M
- Shares bought / sold
- 0 / 230.35K
- Net activity
- Net selling $4.1 million
Beta Bionics insider activity
Over the last 12 months, Beta Bionics insiders reported 47 transactions on SEC Form 4: 0 open-market purchases and 35 sales. Insiders bought $0 and sold $4.1 million worth of stock, for net insider selling of $4.1 million. The largest seller was Hopman Mark, with $2.3 million in reported sales.
The most recent filing shows Hopman Mark (Chief Commercial Officer) selling 370 shares at $18.96 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BBNX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BBNX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | Hopman MarkChief Commercial Officer | Sale | 370 | $7.02K | Form 4 |
| Sep 22, 2026 | Jones ChristyDirector | Sale | 6,430 | $147.89K | Form 4 |
| Sep 16, 2026 | Mensinger MikeChief Product Officer | Sale | 2,650 | $58.30K | Form 4 |
| Sep 16, 2026 | Hopman MarkChief Commercial Officer | Sale | 30,779 | $619.64K | Form 4 |
| Sep 14, 2026 | Hopman MarkChief Commercial Officer | Sale | 775 | $12.03K | Form 4 |
| Sep 9, 2026 | Hopman MarkChief Commercial Officer | Sale | 36,870 | $680.72K | Form 4 |
| Sep 9, 2026 | Hopman MarkChief Commercial Officer | Sale | 35,994 | $664.55K | Form 4 |
| Sep 3, 2026 | Saint SeanPresident & CEO | Sale | 5,641 | $113.26K | Form 4 |
| Sep 2, 2026 | Feider StephenChief Financial Officer | Sale | 6,675 | $127.58K | Form 4 |
| Sep 2, 2026 | Mensinger MikeChief Product Officer | Sale | 4,375 | $83.62K | Form 4 |
| Sep 2, 2026 | Russell Steven JonChief Medical Officer | Sale | 4,221 | $80.68K | Form 4 |
| Sep 2, 2026 | Saint SeanPresident & CEO | Sale | 16,867 | $322.38K | Form 4 |
| Sep 2, 2026 | Hopman MarkChief Commercial Officer | Sale | 5,327 | $101.82K | Form 4 |
| Jun 29, 2026 | Feider StephenChief Financial Officer | Sale | 4,896 | $83.38K | Form 4 |
| Jun 29, 2026 | Feider StephenChief Financial Officer | Option exercise | 4,896 | $24.97K | Form 4 |
| Jun 29, 2026 | Feider StephenChief Financial Officer | Sale | 4,896 | $83.38K | Form 4 |
| Jun 29, 2026 | Feider StephenChief Financial Officer | Option exercise | 4,896 | $24.97K | Form 4 |
| Jun 26, 2026 | Feider StephenChief Financial Officer | Sale | 5,104 | $87.01K | Form 4 |
| Jun 26, 2026 | Feider StephenChief Financial Officer | Option exercise | 4,982 | $25.41K | Form 4 |
| Jun 26, 2026 | Feider StephenChief Financial Officer | Sale | 5,104 | $87.01K | Form 4 |
| Jun 26, 2026 | Feider StephenChief Financial Officer | Option exercise | 5,104 | $26.03K | Form 4 |
| Jun 24, 2026 | Jones ChristyDirector | Sale | 1,406 | $21.09K | Form 4 |
| Jun 24, 2026 | Hopman MarkChief Commercial Officer | Sale | 1,258 | $18.88K | Form 4 |
| Jun 4, 2026 | Jones ChristyDirector | Sale | 2,811 | $39.35K | Form 4 |
| Jun 4, 2026 | Hopman MarkChief Commercial Officer | Sale | 275 | $3.39K | Form 4 |
| Jun 2, 2026 | Saint SeanPresident & CEO | Sale | 16,872 | $212.71K | Form 4 |
| Jun 2, 2026 | Russell Steven JonChief Medical Officer | Sale | 4,222 | $53.23K | Form 4 |
| Jun 2, 2026 | Hopman MarkChief Commercial Officer | Sale | 5,329 | $67.18K | Form 4 |
| Jun 2, 2026 | Mensinger MikeChief Product Officer | Sale | 4,378 | $55.19K | Form 4 |
| Jun 2, 2026 | Feider StephenChief Financial Officer | Sale | 6,676 | $84.17K | Form 4 |
| May 22, 2026 | Lezack AdamDirector | Sale | 998 | $11.19K | Form 4 |
| May 21, 2026 | Lezack AdamDirector | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Lezack AdamDirector | Sale | 1,000 | $9.95K | Form 4 |
| May 21, 2026 | CARNEY SEANDirector | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Dearen Danny L.Director | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Palasis MariaDirector | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Jones ChristyDirector | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Jones ChristyDirector | Sale | 1,998 | $19.88K | Form 4 |
| May 21, 2026 | MICHEL GERARD JDirector | Award | 16,965 | — | Form 4 |
| Mar 4, 2026 | Hopman MarkChief Commercial Officer | Sale | 353 | $4.08K | Form 4 |
| Mar 2, 2026 | Russell Steven JonChief Medical Officer | Sale | 1,026 | $12.68K | Form 4 |
| Mar 2, 2026 | Hopman MarkChief Commercial Officer | Sale | 834 | $10.31K | Form 4 |
| Feb 27, 2026 | Russell Steven JonChief Medical Officer | Award | 109,105 | — | Form 4 |
| Feb 27, 2026 | Hopman MarkChief Commercial Officer | Award | 109,105 | — | Form 4 |
| Dec 4, 2025 | Hopman MarkChief Commercial Officer | Sale | 2,061 | $63.19K | Form 4 |
| Dec 2, 2025 | Hopman MarkChief Commercial Officer | Sale | 856 | $25.11K | Form 4 |
| Dec 2, 2025 | Russell Steven JonChief Medical Officer | Sale | 1,025 | $30.07K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4